DR. BRIAN WALLACE CHRISTMAN, M.D.
Osteopathic Medicine at 24 Ave, Nashville, TN
License number
Tennessee MD0000016603
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
1310 24Th Ave S MEDICAL SERVICE 111, Nashville, TN 37212
Phone
(615) 327-5349
(615) 321-6327 (Fax)
(615) 321-6327 (Fax)
Professional information
Professor And Vice-Chair/Medicine At Vanderbilt University Medical Center
Position:
Professor and Vice-Chair/Medicine at Vanderbilt University Medical Center, Chief, Medical Service at VA Tenn Valley Health Care System, Associate Director, Residency Program in Internal Medicine at Vanderbilt University
Location:
Nashville, Tennessee
Industry:
Higher Education
Work:
Vanderbilt University Medical Center
since Sep 2003
-
Professor and Vice-Chair/Medicine
VA Tenn Valley Health Care System
- Greater Nashville Area of Middle TN since Sep 2003
-
Chief, Medical Service
Vanderbilt University
- Nashville, TN since Sep 2003
-
Associate Director, Residency Program in Internal Medicine
Vanderbilt University
Jul 2010 - Jun 2011
-
Chair, Faculty Senate
Vanderbilt University
Jul 1987 - Sep 2003
-
Asst. and Associate Professor of Medicine
Education:
University of Oklahoma College of Medicine 1977 - 1981
M.D., Medicine Tulane University 1973 - 1977
B.S., Biochemistry
M.D., Medicine Tulane University 1973 - 1977
B.S., Biochemistry
Skills:
Cell Culture, Clinical Research, Cell Biology, Biochemistry, Immunohistochemistry, Science, Animal Models, Healthcare
Brian Wallace Christman, Nashville TN
Specialties:
Pulmonologist
Address:
1310 24Th Ave S, Nashville, TN 37212
Education:
University of Oklahoma, College of Medicine - Doctor of Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Family Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine), American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Dr. Brian W Christman, Nashville TN - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
1310 24Th Ave S, Nashville 37212
(615) 327-4751 (Phone), (615) 873-7743 (Fax)
T1219 Mcn, Nashville 37232
(615) 327-5349 (Phone)
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd STE 400D, Morristown 37813
(423) 586-7509 (Phone), (423) 581-5701 (Fax)
(615) 327-4751 (Phone), (615) 873-7743 (Fax)
T1219 Mcn, Nashville 37232
(615) 327-5349 (Phone)
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd STE 400D, Morristown 37813
(423) 586-7509 (Phone), (423) 581-5701 (Fax)
Certifications:
Critical Care Medicine, 1989, Internal Medicine, 1984, Pulmonary Disease, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1310 24Th Ave S, Nashville 37212
T1219 Mcn, Nashville 37232
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd STE 400D, Morristown 37813
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
T1219 Mcn, Nashville 37232
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd STE 400D, Morristown 37813
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
University of Oklahoma / Health Sciences Center
Graduated: 1981
Vanderbilt University Hospital
Vanderbilt University
University of Oklahoma / Health Sciences Center
Graduated: 1981
Vanderbilt University Hospital
Vanderbilt University
Therapeutic Methods Relating To Human Carbamyl Phosphate Synthetase I Polymorphism
US Patent:
6743823, Jun 1, 2004
Filed:
Jun 1, 2000
Appl. No.:
09/585077
Inventors:
Marshall L. Summar - Brentwood TN
Brian W. Christman - Nashville TN
Brian W. Christman - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31195
US Classification:
514565, 536 232, 536 235, 435 6, 435194
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Human Carbamyl Phosphate Synthetase I Polymorphism And Diagnostic Methods Related Thereto
US Patent:
6346382, Feb 12, 2002
Filed:
Jun 1, 1999
Appl. No.:
09/323472
Inventors:
Marshall L. Summar - Brentwood TN
Brian W. Christman - Nashville TN
Brian W. Christman - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 435 915, 536 232, 536 235, 536 2431, 536 2433, 536 2532
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
2004023, Nov 25, 2004
Filed:
Feb 24, 2004
Appl. No.:
10/785374
Inventors:
Marshall Summar - Brentwood TN, US
Brian Christman - Nashville TN, US
Frederick Barr - Nashville TN, US
Brian Christman - Nashville TN, US
Frederick Barr - Nashville TN, US
Assignee:
Vanderbilt University
International Classification:
A61K031/198
US Classification:
514/565000
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
8536225, Sep 17, 2013
Filed:
Apr 25, 2012
Appl. No.:
13/456014
Inventors:
Marshall L. Summar - Brentwood TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/195
US Classification:
514565
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
8188147, May 29, 2012
Filed:
May 16, 2008
Appl. No.:
12/122117
Inventors:
Marshall L. Summar - Brentwood TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/195
US Classification:
514565
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.